| Literature DB >> 16764747 |
M Isabel Gallegos Sancho1, M Reboredo Lopez, L Calvo Martinez, R Garcia Campelo, M S Lopez Facal, B Sanroman Budino, M Quindos Varela, S Antolin Novoa, M Valladares Ayerbes, G Alonso Curbera, L M Anton Aparicio.
Abstract
We report the case of a patient with subacute cerebellar degeneration presenting as paraneoplastic syndrome, preceding the final diagnosis of breast cancer. The tumor had high HER2 overexpression, so a weekly regimen of paclitaxel/trastuzumab was started after surgery of the primary breast tumor. Negativity of specific antineuronal antibodies and clinical stabilization of the patient was achieved after 12 cycles of treatment. The interest of this case is the unusual presentation and the targeted therapeutic approach that has been used.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16764747 DOI: 10.3816/cbc.2006.n.016
Source DB: PubMed Journal: Clin Breast Cancer ISSN: 1526-8209 Impact factor: 3.225